Drug class
Conjugated equine oestrogens; mixed estrogen-receptor agonist preparation
Mechanism of action
Activates estrogen receptors and regulates transcription of oestrogen-responsive genes in reproductive, bone, vascular and other tissues. The mixture contains multiple estrogenic compounds with differing receptor activity.
General use cases
- Treatment of moderate-to-severe vasomotor symptoms due to menopause
- Treatment of moderate-to-severe vulvar and vaginal atrophy due to menopause
- Prevention of postmenopausal osteoporosis in selected women when alternatives are unsuitable; risk-benefit and progestogen protection depend on uterus status and product label
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
